TP53 and leukoencephalopathy with calcifications and cysts: Furthermore, although there was no significant difference, all four LCC patients under the 2015 WHO criteria who did not harbor TP53 mutations were alive at the time of follow-up and might present better prognoses compared with the other patients in this cohort.